TL;DR
This study integrates genetic and epigenetic data to map the molecular underpinnings of inflammatory protein levels in healthy older adults. By employing a novel Bayesian framework, the researchers identified key genetic and epigenetic markers that influence these protein levels, revealing potential causal links between specific inflammatory proteins and diseases like inflammatory bowel disease and Crohn's disease.
What Problem Does This Paper Address?
Circulating inflammatory proteins play a crucial role in health and disease, but the factors controlling their levels in the body are not fully understood. Traditional association studies often use linear models that struggle to account for the complex relationships and structures within large molecular datasets (like genetic and epigenetic data). This can lead to inaccurate estimates of how these molecular factors influence protein levels. This paper aims to address this by using a more sophisticated approach to identify the genetic and epigenetic architecture of inflammatory protein levels and understand their contribution to inter-individual variability.
Methods
The researchers utilized a Bayesian penalized regression framework called BayesR+. This method is particularly useful because it can simultaneously analyze genetic (SNPs) and epigenetic (CpG sites) data, accounting for complex data structures and potential confounding variables. They also performed sensitivity analyses using Ordinary Least Squares (OLS) and mixed-model based approaches to ensure the robustness of their findings.
Key methodological aspects include:
- Genome-wide association studies (GWAS) to identify genetic variants (SNPs) associated with protein levels.
- Epigenome-wide association studies (EWAS) to identify epigenetic markers (CpG sites) associated with protein levels.
- Colocalization analysis to determine if the same causal variant underlies both genetic and epigenetic associations with protein levels, or if they are independent.
- Mendelian Randomization (MR) to investigate putatively causal relationships between identified genetic variants, gene expression, DNA methylation, and protein levels, as well as between protein levels and human traits/diseases.
Datasets
The study used data from the Lothian Birth Cohort 1936 (LBC1936), a longitudinal aging study.
- Participants: 876 healthy older adults.
- Protein Data: Levels of 70 plasma-derived inflammatory protein biomarkers measured using the Olink® inflammation panel.
- Genetic Data: Genotyping data from the Illumina 610-Quadv1 array (n=1005).
- Epigenetic Data: DNA methylation data from whole blood using the Infinium 450 K methylation array (n=876).
Key Insights and Ideas
- Integrated Omics Approach is Powerful: Combining genetic and epigenetic data provides a more comprehensive understanding of protein regulation than looking at each type of data in isolation.
- Bayesian Framework Outperforms Linear Models: The BayesR+ approach effectively handles complex data structures and provides more reliable estimates of variance explained by genetic and epigenetic factors.
- Genetic and Epigenetic Factors Cooperate: Both genetic variants and DNA methylation play significant roles in determining inflammatory protein levels, and their combined effect can explain a substantial portion of the variation.
- Identifying Potential Causal Links: The study moved beyond simple associations to suggest causal relationships between specific inflammatory proteins and diseases, opening doors for targeted interventions.
Key Results
- Genetic Associations: Identified 13 SNPs concordantly associated with 13 inflammatory proteins across Bayesian and OLS models. These SNPs explained up to 45% of the variance in protein levels (e.g., 36% for MCP2 by a single SNP).
- Epigenetic Associations: Identified 3 CpG sites concordantly associated with 3 inflammatory proteins across OLS, mixed-model, and Bayesian analyses. Methylation data accounted for up to 46% of variation in protein levels (for CXCL10).
- Combined Variance Explained: For some proteins, the combined effect of genetic and methylation data explained a substantial amount of variance, reaching up to 66% for VEGFA.
- Causal Relationships: Demonstrated putative causal relationships between:
- CD6 levels and inflammatory bowel disease (IBD).
- IL18R1 levels and IBD.
- IL12B levels and Crohn's disease.
- FGF-5 levels and systolic/diastolic blood pressure.
Limitations and Future Work
- Cohort Homogeneity: The study cohort was primarily Scottish, which may limit the generalizability of findings to other ethnic backgrounds.
- Ageing Effects: The cohort consisted of older adults, and the distribution and correlation of inflammatory protein biomarkers might differ in younger age groups.
- Sample Size and Confidence Intervals: The sample size led to large confidence and credible intervals for heritability estimates.
- Protein Homology: Proteins with high sequence homology could lead to quantification errors in the assay.
- Correlation Structure: The strong correlation structure among inflammatory proteins, while potentially reflecting biological co-regulation, can also complicate analysis.
Future work could involve validating these findings in diverse populations, exploring the functional mechanisms underlying the identified associations in more detail, and investigating the therapeutic potential of targeting these inflammatory pathways.
Summary updated